170 related articles for article (PubMed ID: 21228137)
1. Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.
Simon JK; Ramirez K; Cuberos L; Campbell JD; Viret JF; Muñoz A; Lagos R; Levine MM; Pasetti MF
Clin Vaccine Immunol; 2011 Mar; 18(3):355-61. PubMed ID: 21228137
[TBL] [Abstract][Full Text] [Related]
2. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
Liashenko VA; Krasnova VP; Youminova NV
Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
[TBL] [Abstract][Full Text] [Related]
3. A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.
Simon JK; Pasetti MF; Viret JF; Mischler R; Muñoz A; Lagos R; Levine MM; Campbell JD
Hum Vaccin; 2007; 3(2):54-8. PubMed ID: 17312403
[TBL] [Abstract][Full Text] [Related]
4. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
Ainai A; van Riet E; Ito R; Ikeda K; Senchi K; Suzuki T; Tamura SI; Asanuma H; Odagiri T; Tashiro M; Kurata T; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
Microbiol Immunol; 2020 Apr; 64(4):313-325. PubMed ID: 31957054
[TBL] [Abstract][Full Text] [Related]
5. Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine.
Bellanti JA; Zeligs BJ; Mendez-Inocencio J; García-Garcia ML; Islas-Romero R; Omidvar B; Omidvar J; Kim G; Fernandez De Castro J; Sepulveda Amor J; Walls L; Bellini WJ; Valdespino-Gomez JL
Vaccine; 2004 Mar; 22(9-10):1214-20. PubMed ID: 15003650
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with the recombinant measles virus encoding the spike protein of SARS-CoV-2 confers protective immunity against COVID-19 in hamsters.
Park SI; Park S; Lee K; Kwak HW; Kim YK; Park HJ; Bang YJ; Kim JY; Kim D; Seo KW; Lee SJ; Kim H; Kim Y; Kim DH; Park HJ; Jung SY; Ga E; Hwang J; Na W; Hong SH; Lee SM; Nam JH
Vaccine; 2024 Jan; 42(2):69-74. PubMed ID: 38097457
[TBL] [Abstract][Full Text] [Related]
7. Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice.
de Haan A; Tomee JF; Huchshorn JP; Wilschut J
Vaccine; 1995 Oct; 13(14):1320-4. PubMed ID: 8585287
[TBL] [Abstract][Full Text] [Related]
8. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
[TBL] [Abstract][Full Text] [Related]
9. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML
J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults.
Ainai A; Tamura S; Suzuki T; van Riet E; Ito R; Odagiri T; Tashiro M; Kurata T; Hasegawa H
Hum Vaccin Immunother; 2013 Sep; 9(9):1962-70. PubMed ID: 23896606
[TBL] [Abstract][Full Text] [Related]
11. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
[TBL] [Abstract][Full Text] [Related]
12. Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.
Bakke H; Samdal HH; Holst J; Oftung F; Haugen IL; Kristoffersen AC; Haugan A; Janakova L; Korsvold GE; Krogh G; Andersen EA; Djupesland P; Holand T; Rappuoli R; Haneberg B
Scand J Immunol; 2006 Mar; 63(3):223-31. PubMed ID: 16499576
[TBL] [Abstract][Full Text] [Related]
13. Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects.
Treanor J; Nolan C; O'Brien D; Burt D; Lowell G; Linden J; Fries L
Vaccine; 2006 Jan; 24(3):254-62. PubMed ID: 16129526
[TBL] [Abstract][Full Text] [Related]
14. Both systemic and mucosal LCMV immunization generate robust viral-specific IgG in mucosal secretions, but elicit poor LCMV-specific IgA.
Rajini B; Zeng J; Suvas PK; Dech HM; Onami TM
Viral Immunol; 2010 Aug; 23(4):377-84. PubMed ID: 20712482
[TBL] [Abstract][Full Text] [Related]
15. The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.
Chan RWY; Liu S; Cheung JY; Tsun JGS; Chan KC; Chan KYY; Fung GPG; Li AM; Lam HS
Front Immunol; 2021; 12():744887. PubMed ID: 34712232
[TBL] [Abstract][Full Text] [Related]
16. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.
Terauchi Y; Sano K; Ainai A; Saito S; Taga Y; Ogawa-Goto K; Tamura SI; Odagiri T; Tashiro M; Fujieda M; Suzuki T; Hasegawa H
Hum Vaccin Immunother; 2018 Jun; 14(6):1351-1361. PubMed ID: 29425074
[TBL] [Abstract][Full Text] [Related]
17. [Systemic B-cell response in the mouse after mucosal immunization with measles virus].
Muller CP; Brons NH
Immun Infekt; 1994 Jun; 22(3):125-6. PubMed ID: 7927470
[TBL] [Abstract][Full Text] [Related]
18. Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh.
Hayford KT; Al-Emran HM; Moss WJ; Shomik MS; Bishai D; Levine OS
J Virol Methods; 2013 Nov; 193(2):512-8. PubMed ID: 23872267
[TBL] [Abstract][Full Text] [Related]
19. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.
Moldoveanu Z; Clements ML; Prince SJ; Murphy BR; Mestecky J
Vaccine; 1995 Aug; 13(11):1006-12. PubMed ID: 8525683
[TBL] [Abstract][Full Text] [Related]
20. Induction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults.
Fujimoto C; Takeda N; Matsunaga A; Sawada A; Tanaka T; Kimoto T; Shinahara W; Sawabuchi T; Yamaguchi M; Hayama M; Yanagawa H; Yano M; Kido H
Influenza Other Respir Viruses; 2012 Nov; 6(6):396-403. PubMed ID: 22226319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
